Needham & Co downgrades Dyax Corp. (Nasdaq: DYAX) to Hold.

Needham analyst says, "Yesterday, the Pulmonary-Allergy Drugs Advisory Committee ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE